CP
OFIX icon

Castleview Partners’s Orthofix Medical OFIX Stock Holding History

Castleview Partners’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$43K Buy
+1,060
New +$44.8K 0.02% 444
2018
Q1 		$327K Buy
+5,555
New +$311K 0.27% 83

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Castleview Partners's OFIX Position: Q2 2021 in Review

Castleview Partners opened a new position in Orthofix Medical (OFIX) in Q2 2021: 1,060 shares worth $43K. The stake represents 0.02% of the portfolio and ranks #444 among its holdings. This is a return to the name: Castleview Partners previously reported a position in OFIX as recently as Q1 2018.

Castleview Partners first reported a position in OFIX in Q1 2018 and has held it in 2 quarters since. The position peaked at $327K in Q1 2018. 134 funds tracked by Wall St. Rank hold OFIX as of Q2 2021.

  • Castleview Partners held 1,060 shares of Orthofix Medical worth $43K as of Q2 2021.
  • Orthofix Medical was a new Castleview Partners position in Q2 2021.
  • Orthofix Medical made up 0.02% of Castleview Partners's portfolio in Q2 2021, its #444 holding.
  • Castleview Partners first reported a position in Orthofix Medical in Q1 2018 and has held it in 2 quarters since.
  • Castleview Partners's Orthofix Medical position peaked at $327K in Q1 2018.
  • 134 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.